Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Melissa La Mar
Poly-Iclc, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Frontiers in Immunology
Allergy
Immunology
Related publications
Nephroprotection by Theophylline in Patients With Cisplatin Chemotherapy: A Randomized, Single-Blinded, Placebo-Controlled Trial
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
Gastroenterology
Hepatology
Gastroenterology
Effects of Lactoferrin on Subjective Skin Conditions in Winter: A Preliminary, Randomized, Double-Blinded, Placebo-Controlled Trial
Clinical, Cosmetic and Investigational Dermatology
Dermatology
Innate Immune Responses in Primary HIV-1 Infection
Current Opinion in HIV and AIDS
Virology
Oncology
Infectious Diseases
Immunology
Hematology
Correction To: Are the Ergogenic Effects of Photobiomodulation Therapy Age-Dependent? A Randomized Double-Blinded Placebo-Controlled Trial
Lasers in Medical Science
Dermatology
Surgery
Spectral Biomarkers for Chemoprevention of Colonic Neoplasia: A Placebo-Controlled Double-Blinded Trial With Aspirin
Gut
Gastroenterology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
